These are animal vaccines. None of them is a vaccine for people. Every product on these pages is authorised for the animal species named in its row, by the UK Veterinary Medicines Directorate. A product licensed for cattle or poultry says nothing about whether protection exists for a person, and several of these viruses do not infect people at all.
Looking for human vaccines? Use the main Virus Navigator.
At a glance
| Abbreviation | FLUAV |
|---|---|
| ICTV species | Alphainfluenzavirus influenzae |
| Family | Orthomyxoviridae |
| Baltimore class | V — (−)ssRNA |
| Human infection | Human infection recorded; pattern not classified |
Also called: Alphainfluenzavirus influenzae
Riboviria › Negarnaviricota › Insthoviricetes › Articulavirales › Orthomyxoviridae › Alphainfluenzavirus
What it is
Taxonomy copied from ICTV MSL41.v1 / VMR_MSL41.v1.20260729.xlsx. These ranks are not hand-edited; a correction means re-running the fetch against a newer release.
| Realm | Riboviria |
|---|---|
| Kingdom | Orthornavirae |
| Phylum | Negarnaviricota |
| Class | Insthoviricetes |
| Order | Articulavirales |
| Family | Orthomyxoviridae |
| Genus | Alphainfluenzavirus |
| ICTV identifier | ICTV19710226 |
| NCBI taxon | 2955291 |
| Exemplar isolate | RNA1: V00603; RNA2: J02151; RNA3: V01106; RNA4: V01088; RNA5: J02147; RNA6: J02146; RNA7: V01099; RNA8: J02150 |
| Genome | Segmented, 8 segments |
Host evidence
- human: 831,020 GenBank records
- pig: 22,867 GenBank records
- duck: 19,068 GenBank records
- chicken: 12,446 GenBank records
- horse: 5,572 GenBank records (flagged for review)
- dog: 1,624 GenBank records (flagged for review)
- turkey: 401 GenBank records (flagged for review)
- cattle: 344 GenBank records (flagged for review)
- cat: 63 GenBank records (flagged for review)
Counts of nucleotide records annotated with that host. Evidence of provenance, not a statement of host range.
Where it occurs
Not searched yet. No country-level occurrence data has been curated for this virus. The WHO reported-case data on this site covers a limited set of diseases; a virus outside it gets no map rather than an empty one.
What it does
Each figure is the one its source printed, with the sentence it came from. Nothing is recomputed, averaged or converted.
Burden
| Measure | As the source states it | Source |
|---|---|---|
| Annual Deaths | 290 000 to 650 000 respiratory deaths annuallyglobal | quoteIt causes 290 000 to 650 000 respiratory deaths annually. Influenza (seasonal) fact sheet · source · verified 2026-10-30 |
Transmission and spread
| Measure | As the source states it | Source |
|---|---|---|
| Incubation Period | 1-4 daysglobal | quoteSymptoms begin 1-4 days after infection and usually last around a week. Influenza (seasonal) fact sheet · source · verified 2026-10-30 |
More, with study designs and vaccine efficacy: disease-risk page.
Vaccines
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| BioEquin F Suspension for Injection for Horses | Bioveta, a.s. | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A014023 (VM 46608/3005); active substance 'Equine influenz |
| BioEquin FT Suspension for Injection for Horses | Bioveta, a.s. | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A014024 (VM 46608/3006); active substance 'Equine influenz |
| Equilis Prequenza Te Suspension for Injection for Horses | MSD Animal Health UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A006247 (VM 01708/5031); active substance 'Equine influenz |
| Equilis Prequenza, Suspension for Injection, for Horses | MSD Animal Health UK Limited | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A006246 (VM 01708/5032); active substance 'Equine influenz |
| Equip F | Zoetis UK Limited | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A002907 (VM 42058/5231); active substance 'Equine influenz |
| Equip FT Suspension for Injection | Zoetis UK Limited | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A002885 (VM 42058/5163); active substance 'Equine influenz |
| Nobilis Influenza H5N2 Emulsion for Injection for Chickens | MSD Animal Health UK Limited | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A006825 (VM 01708/5044); active substance 'Avian influenza |
| ProteqFlu Suspension for Injection for Horses | Boehringer Ingelheim Vetmedica GmbH | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A006565 (VM 61700/5076); active substance 'Equine influenz |
| ProteqFlu-Te Suspension for Injection for Horses | Boehringer Ingelheim Vetmedica GmbH | Not searched yet | Routine immunisation | Approved | UK: approved | — | VMD product A006564 (VM 61700/5077); active substance 'Equine influenz |
| Respiporc Flu3 Suspension for Injection for Pigs | Ceva Animal Health Ltd | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A007409 (VM 15052/5016); active substance 'Swine influenza |
| RESPIPORC FLUpan H1N1 | Ceva Sante Animale | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A011152 (VM EU/2/17/209/001–002); active substance 'Swine |
| RESPIPORC FLUpan H1N1 Suspension for Injection for Pigs | Ceva Animal Health Ltd | inactivated whole | Routine immunisation | Approved | UK: approved | — | VMD product A009475 (VM 15052/5017); active substance 'Swine influenza |
| Vaxxinact H5 Emulsion for Injection | Boehringer Ingelheim Vetmedica GmbH | live attenuated | Routine immunisation | Approved | UK: approved | — | VMD product A014789 (VM EU/2/25/356/001-002); active substance 'Avian |
Antivirals
Not searched yet. No US-approved antiviral for this virus was found in the openFDA drug label endpoint. Only US labels were searched, and only drugs the FDA classes as antivirals.
Antibodies and immune globulins
Not searched yet. No US-approved antiviral antibody for this virus was found in the openFDA drug label endpoint.
Approval status is not a treatment recommendation. Dosing and eligibility are on the label and in national guidelines. This page does not give medical advice and does not render dosing. A development stage is not a measure of how well something works.
Related on this site
- Disease risk and vaccine efficacy — burden figures and trial results, each quoted from its source
- Influenza vaccine — ingredients, schedule and reported side effects
- Vaccine pipeline — candidates listed under “Influenza”
- Other Orthomyxoviridae viruses
- The human page for this virus — people, kept separate on purpose